Related Experiment Video
Updated: Oct 19, 2026

Human Circadian Phenotyping and Diurnal Performance Testing in the Real World
Published on: April 7, 2020
Distinct daytime sleepiness phenotypes across insomnia symptom dimensions in the Wisconsin sleep cohort
Yixuan Wang1, Jiali Xiong1, Qingfeng Zhang1
1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
Background:
Insomnia symptoms are heterogeneous, and it remains unclear whether difficulty initiating sleep (DIS), difficulty maintaining sleep (DMS), operationalized as repeated nighttime awakening, and early morning awakening (EMA) correspond to distinct joint patterns of subjective daytime sleepiness and physiological sleep propensity. We examined these symptom-specific phenotypes and their clinical burden.
Methods:
We analyzed 881 Wisconsin Sleep Cohort participants with complete Epworth Sleepiness Scale (ESS) and Multiple Sleep Latency Test (MSLT) data. Four phenotypes were defined by ESS >10 and MSLT <8 min: Neither, Subjective-only, Objective-only, and Both. DIS, DMS, and EMA were assessed using self-reported questionnaire items and were entered simultaneously in adjusted multinomial logistic regression.
Results:
Greater DIS severity was associated with lower ESS (β = -0.70, 95% confidence interval (CI) -1.02 to -0.39), longer MSLT latency (β = 0.45 min, 95% CI 0.10 to 0.80), and lower relative risk of Both (relative risk ratio (RRR) = 0.67, 95% CI 0.52 to 0.87). Greater DMS severity was associated with higher ESS (β = 0.43, 95% CI 0.20 to 0.66) and higher relative risk of Both (RRR = 1.30, 95% CI 1.09 to 1.56). EMA was not associated with the overall phenotype distribution. Within frequent DMS, Subjective-only sleepiness was associated with higher depression and trait anxiety after false discovery rate adjustment.
Conclusions:
DIS and DMS were associated with different daytime sleepiness profiles. Within frequent DMS, subjective sleepiness identified greater psychological burden. The observed associations were generally modest and support considering nocturnal symptom pattern when interpreting daytime sleepiness.
Related Concept Videos
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Insomnia
Multiple factors contribute...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Narcolepsy
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

